Protagenic Therapeutics exec chair Garo H. Armen acquires 5,000 common shares for $1,294
PTIX•Armen buys additional Protagenic Therapeutics shares
Garo H. Armen, executive chair and principal officer of Protagenic Therapeutics, bought 5,000 common shares at $0.26 per share.
Armen’s direct holding rose to 31,294 common shares.
